82601-41-0 Usage
Uses
Used in Cancer Therapy:
Pseudolaric Acid C is used as an anti-cancer agent for its ability to inhibit the growth of various cancer cells and induce apoptosis, making it a potential candidate for cancer treatment.
Used in Inflammatory Disease Treatment:
Pseudolaric Acid C is used as an anti-inflammatory agent for its ability to alleviate inflammation, making it a potential candidate for the treatment of inflammatory diseases.
Used in Fungal Disease Treatment:
Pseudolaric Acid C is used as an anti-fungal agent for its ability to combat fungal infections, making it a potential candidate for the treatment of fungal diseases.
Used in Pharmaceutical Research and Development:
Pseudolaric Acid C is used as a subject of interest for further research and potential development of pharmaceutical applications due to its unique structure and potent biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 82601-41-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,6,0 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 82601-41:
(7*8)+(6*2)+(5*6)+(4*0)+(3*1)+(2*4)+(1*1)=110
110 % 10 = 0
So 82601-41-0 is a valid CAS Registry Number.
InChI:InChI=1/C21H26O7/c1-13(16(22)23)5-4-9-19(2)15-8-11-20(18(25)28-19)10-6-14(17(24)27-3)7-12-21(15,20)26/h4-6,9,15,26H,7-8,10-12H2,1-3H3,(H,22,23)/b9-4+,13-5+/t15-,19+,20+,21-/m0/s1
82601-41-0Relevant academic research and scientific papers
Chen, Shou-Qiang,Wang, Jie,Zhao, Chuan,Sun, Qiang-Wen,Wang, Yi-Teng,Ai, Ting,Li, Tan,Gao, Ying,Wang, Huo,Chen, Hong
, p. 828 - 837 (2015)
Pseudolaric acid B (PB) derivatives with immunosuppressive activity were found by our group. In order to find potential immunosuppressive agents with high efficacy and low toxicity, a series of novel PB derivatives were synthesized and evaluated on their immunosuppressive activities. Most of the synthesized compounds were tested in vitro on murine T and B proliferation. In particular, compound 11 exhibited excellent inhibitory activity toward murine T cells (up to 19-fold enhancement compared to that of mycophenolatemofetil) and little cytotoxicity toward normal murine spleen cells. These experimental data demonstrated that some of these PB derivatives have great potential for future immunosuppressive studies.
